Contributions of Department of Biotechnology to non-communicable disease biology research in India

被引:0
|
作者
Shenoy, Sandhya R. [1 ]
机构
[1] Dept Biotechnol, Med Biotechnol Div, Human Genom & Oncol Unit, Block 2,CGO Complex,Lodi Rd, New Delhi 110003, India
来源
CURRENT SCIENCE | 2022年 / 123卷 / 02期
基金
英国医学研究理事会;
关键词
Bio-banks; cohort study; funding agency; non-communicable diseases; partnership centres;
D O I
10.18520/cs/v123/i2/148-153
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The last two decades have seen a shift of focus from communicable to non-communicable diseases (NCDs). NCDs, including cancer, diabetes, cardiovascular diseases, chronic lung disease, chronic kidney disease, neurological disorders, etc., pose devastating health consequences for individuals, families and communities, and threaten health systems. The socio-economic costs associated with these chronic diseases make their control a global priority. The Department of Biotechnology is working to provide leadership and evidence-based actions on surveillance, prevention and control of NCDs to reduce the disease burden. The Department of Biotechnology (DBT) aims to develop and support competitive research and development (R&D) programmes and generate new programmes from basic to clinical and transla-tional research under NCD conditions. Diseases addressed in the programme include but are not limited to cancer, diabetes, hypertension, cardiovascular diseases, lung diseases, kidney disorders, autoimmune disorders, eye diseases, osteoporosis and bone biology, diseases of the gastrointestinal system, neurological disorders, etc. This article summarizes the contributions of DBT to NCD biology research in India through finan-cial support.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
  • [31] The Economic impact of Non-communicable Diseases on households in India
    Michael M Engelgau
    Anup Karan
    Ajay Mahal
    Globalization and Health, 8
  • [32] Metabolic non-communicable diseases in India: time to act
    Habeeb, Shifa
    Thankappan, Kavumpurathu Raman
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (12): : 897 - 898
  • [33] The Economic impact of Non-communicable Diseases on households in India
    Engelgau, Michael M.
    Karan, Anup
    Mahal, Ajay
    GLOBALIZATION AND HEALTH, 2012, 8
  • [34] A global research network for non-communicable diseases
    Smith, Richard
    Rabadan-Diehl, Christina
    Wu, Yangfeng
    Niessen, Louis
    Prabhakaran, Dorajai
    Xavier, Denis
    Ghannem, Hassen
    Kimaiyo, Sylvester
    Levitt, Naomi
    Denman, Catalina A.
    Ramirez-Zea, Manuel
    Miranda, Jaime
    Rubenstein, Adolfo
    LANCET, 2014, 383 (9927): : 1446 - 1447
  • [35] The MILLET MISSION: The potential to combat non-communicable diseases and future research opportunities in India
    Ramanathan, Vanisree
    Tripathi, Shailesh
    Bhattacharya, Sudip
    Jahnavi, G.
    Gupta, Pratima
    Varshney, Saurabh
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2023, 35 (02) : 246 - 249
  • [36] Patterns of non-communicable disease multimorbidity among persons with non-communicable diseases in Addis Ababa, Ethiopia
    Addissie, Adamu
    Zelalem, Yeabsera
    Wondimagegnehu, Abigiya
    Mamushet, Yared
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 : 251 - 251
  • [37] Rethinking the terms non-communicable disease and chronic disease
    Ackland, M
    Choi, BCK
    Puska, P
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (11) : 838 - 839
  • [38] Principles for the prevention and control of non-communicable disease
    Mohan, Sailesh
    Khunti, Kamlesh
    Prabhakaran, Dorairaj
    NATURE MEDICINE, 2023, 29 (07) : 1598 - 1600
  • [39] FROM THE FRONTLINE Exploiting non-communicable disease
    Spence, Des
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [40] Non-communicable disease surveillance in developing countries
    Steyn, K
    Bradshaw, D
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2001, 29 (03) : 161 - 165